Newcourt Acquisition Yönetim

Yönetim kriter kontrolleri 0/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Marc Balkin

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	2.8yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	2.3yrs

Son yönetim güncellemeleri

Recent updates

CEO

Marc Balkin (49 yo)

2.8yrs

Görev süresi

Mr. Marc Gregory Balkin has been Chief Executive Officer and Director at Newcourt Acquisition Corp since March 2021. Mr. Balkin founded of Balkin and Co in 2015. He was a Partner at Hasso Plattner Ventures...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Marc Balkin	CEO & Director	2.8yrs	Veri yok	Veri yok
Ryan Gilbert	Member of Advisory Board	no data	Veri yok	Veri yok
Michael Jordaan	Chairman of the Board	2.8yrs	Veri yok	Veri yok
Rohit Bodas	Independent Director	2.3yrs	Veri yok	Veri yok
Simran Aggarwal	Independent Director	2.3yrs	Veri yok	Veri yok
Nicole Farb	Independent Director	2.3yrs	Veri yok	Veri yok

2.3yrs

Ortalama Görev Süresi

48.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: NCAC.U's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.

Newcourt Acquisition Yönetim

Yönetim kriter kontrolleri 0/4

Anahtar bilgiler

Son yönetim güncellemeleri

Newcourt Acquisition Corp Announces Resignation of Daniel Rogers as Daniel Rogers

Recent updates

Newcourt Acquisition Files Form 15

Newcourt Acquisition's Ordinary Shares, Units to Be Delisted and Deregistered Under Section 12(b) of the Exchange Act

Psyence Therapeutics Corp. completed the acquisition of Newcourt Acquisition Corp (NasdaqGM:NCAC) from Newcourt SPAC Sponsor LLC, Polar Asset Management Partners Inc. and others in a reverse merger transaction.

Newcourt Acquisition Corp announced that it expects to receive $10 million in funding from Psyence Therapeutics Corp.

Newcourt Acquisition Corp announced delayed 10-Q filing

Newcourt Acquisition Regains Compliance with the Market Value of Listed Securities Rule

Newcourt Acquisition Regains Compliance with the Market Value of Listed Securities Rule

Newcourt Acquisition Receives Non-Compliance Notice From Nasdaq

Newcourt Acquisition Receives Non-Compliance Notice From Nasdaq

Newcourt Acquisition Corp announced that it expects to receive $0.75 million in funding from Newcourt SPAC Sponsor LLC

Newcourt Acquisition Corp Announces Resignation of Daniel Rogers as Daniel Rogers

Psyence Therapeutics Corp. entered into a definitive business combination agreement to acquire Newcourt Acquisition Corp (NasdaqGM:NCAC) from Newcourt SPAC Sponsor LLC and others for $50 million in a reverse merger transaction.

Newcourt Acquisition Corp announced delayed annual 10-K filing

CEO

Görev süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş